Redistribution of CD163+ CCR2+ Monocytes from Blood Circulation to the Ascites as a Potential Indicator of Progression in High-Grade Serous Ovarian Cancer

This study aimed to identify tumor-specific changes in circulating and ascites-derived monocytes from high-grade serous ovarian carcinoma (HGSOC) patients using flow cytometry, immunohistochemistry, RNA sequencing, and in vitro experiments. Our results demonstrate that the tumor induces a decrease in the total number of circulating monocytes but an increase in the proportion of CD163+ monocytes. Notably, CD206-expressing monocytes were reduced in HGSOC patients, with extremely low CD206 levels in peripheral blood mirroring those in tumor tissues. In contrast, a marked accumulation of CD206-positive monocyte-derived macrophages was observed in malignant ascites. The presence of CCR2 on the monocyte surface further amplified the increase in CD163+ monocytes and reversed the decrease in CD206+ monocytes in cancer patients. Transcriptional levels of CD163 corresponded to protein levels and were elevated in monocytes of HGSOC patients. Moreover, the percentage of CD163+CCR2+ monocytes was decreased in peripheral blood but increased in ascites of patients with progressive disease. A functional migration assay confirmed extensive recruitment of monocytes toward malignant ascites in vitro. Collectively, our findings suggest that the redistribution of CD163+CCR2+ monocytes from blood to malignant ascites may represent a candidate indicator of disease progression in HGSOC patients.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-19
DOI
https://doi.org/10.3390/ijms272210437
Primary Topic
Immune cells in cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Redistribution of CD163+ CCR2+ Monocytes from Blood Circulation to the Ascites as a Potential Indicator of Progression in High-Grade Serous Ovarian Cancer

Julia G. Kzhyshkowska, Anna Valerievna Kalinchuk, Tatiana Sudarskikh, Irina Larionova et al.
International Journal of Molecular Sciences
Immune cells in cancer
article

Redistribution of CD163+ CCR2+ Monocytes from Blood Circulation to the Ascites as a Potential Indicator of Progression in High-Grade Serous Ovarian Cancer

Julia G. Kzhyshkowska, Anna Valerievna Kalinchuk, Tatiana Sudarskikh, Irina Larionova, Pavel S. Iamshchikov, Л. А. Коломиец, Shuo Chen, Evgeniya S. Grigoryeva, Kseniia Shalygina, Анна Казакова, Yang Zhao, Svetlana Iamshchikova, Alexandr Yatskovskyi, Alisa Villert
article en

Abstract

This study aimed to identify tumor-specific changes in circulating and ascites-derived monocytes from high-grade serous ovarian carcinoma (HGSOC) patients using flow cytometry, immunohistochemistry, RNA sequencing, and in vitro experiments. Our results demonstrate that the tumor induces a decrease in the total number of circulating monocytes but an increase in the proportion of CD163+ monocytes. Notably, CD206-expressing monocytes were reduced in HGSOC patients, with extremely low CD206 levels in peripheral blood mirroring those in tumor tissues. In contrast, a marked accumulation of CD206-positive monocyte-derived macrophages was observed in malignant ascites. The presence of CCR2 on the monocyte surface further amplified the increase in CD163+ monocytes and reversed the decrease in CD206+ monocytes in cancer patients. Transcriptional levels of CD163 corresponded to protein levels and were elevated in monocytes of HGSOC patients. Moreover, the percentage of CD163+CCR2+ monocytes was decreased in peripheral blood but increased in ascites of patients with progressive disease. A functional migration assay confirmed extensive recruitment of monocytes toward malignant ascites in vitro. Collectively, our findings suggest that the redistribution of CD163+CCR2+ monocytes from blood to malignant ascites may represent a candidate indicator of disease progression in HGSOC patients.

International Journal of Molecular SciencesVol. 27(22)
Russian Academy of Sciences (RU), National Research Tomsk State University (RU), Heidelberg University (DE), Third Affiliated Hospital of Guangzhou Medical University (CN), Tomsk National Research Medical Center (RU), Tomsk Cancer Research Institute (RU), Liaoning Cancer Hospital & Institute (CN), Medizinische Fakultät Mannheim (DE), Guangzhou Medical University (CN)
Immune cells in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon